Lurbinectedin is a chemotherapy drug that is used to treat certain types of cancer, including small cell lung cancer. While it can be effective in treating cancer, it can also cause a range of side effects.

The most common side effects of lurbinectedin include fatigue, nausea, vomiting, constipation, decreased appetite, and diarrhea. Patients may also experience hair loss, anemia, and low white blood cell counts. In some cases, patients may experience more serious side effects, such as infections, bleeding, or liver damage.

Patients who are receiving lurbinectedin should be closely monitored by their healthcare provider to ensure that they are not experiencing any serious side effects. It is important for patients to report any side effects to their healthcare provider, as they may need to adjust the dose or provide additional treatment to manage these symptoms.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN
[2] https://www.mayoclinic.org/drugs-supplements/lurbinectedin-intravenous-route/side-effects/drg-20490804?p=1
[3] https://www.zepzelca.com/zepzelca-side-effects/